Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.

Literature DB >> 16208666

Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.

Nadera J Sweiss¹, Michael Jude Welsch, James J Curran, Michael H Ellman.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2005 PMID： 16208666 DOI： 10.1002/art.21468

Source DB: PubMed Journal: Arthritis Rheum ISSN： 0004-3591

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. Adalimumab for refractory pulmonary sarcoidosis.

Authors: P A Minnis; M Poland; M P Keane; S C Donnelly
Journal: Ir J Med Sci Date: 2015-10-01 Impact factor: 1.568

2. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.

Authors: D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; P Emery; E C Keystone; M H Schiff; P L C M van Riel; M E Weinblatt; M H Weisman
Journal: Ann Rheum Dis Date: 2006-11 Impact factor: 19.103

Review 3. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors: D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal: Ann Rheum Dis Date: 2007-11 Impact factor: 19.103

4. Infliximab therapy for hepatic and intestinal sarcoidosis.

Authors: Helen S Te; Lucas Campbell; Saima Chohan
Journal: Gastroenterol Hepatol (N Y) Date: 2007-06

5. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.

Authors: Nadera J Sweiss; Imre Noth; Mehdi Mirsaeidi; Wei Zhang; Edward T Naureckas; D Kyle Hogarth; Mary Strek; Philip Caligiuri; Roberto F Machado; Timothy B Niewold; Joe G N Garcia; Aileen L Pangan; Robert P Baughman
Journal: Sarcoidosis Vasc Diffuse Lung Dis Date: 2014-04-18 Impact factor: 0.670

Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.

Review 1. Adalimumab for refractory pulmonary sarcoidosis.

2. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.

Review 3. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

4. Infliximab therapy for hepatic and intestinal sarcoidosis.

5. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.

6. Refractory multisystem sarcoidosis responding to infliximab therapy.

Review 7. Cytokine modulators in the treatment of sarcoidosis.

8. Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab.

Review 9. Evidence-based therapy for cutaneous sarcoidosis.

10. Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.